Myositis specific antibodies: Frequency in different populations

Folia Neuropathologica

Volumn 38, Issue 3, 2000, Pages 101-103

  Kowalska Oledzka, Elzbieta ^a   Stern, Lawrence Z ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Idiopathic inflammatory myopathies; Myositis specific autoantibodies

Indexed keywords

ALANINE TRANSFER RNA ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; CHROMODOMAIN HELICASE DNA BINDING PROTEIN ANTIBODY; CYTOPLASM ANTIBODY; GLYCINE TRANSFER RNA ANTIBODY; HISTIDINE TRANSFER RNA LIGASE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; SIGNAL RECOGNITION PARTICLE ANTIBODY; STEROID; SYNTHETASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ANTISYNTHETASE SYNDROME; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FREQUENCY ANALYSIS; HUMAN; INTERSTITIAL LUNG DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MYOSITIS; NEUROMUSCULAR DISEASE; NORTH AMERICA; ONSET AGE; POLAND; POPULATION RESEARCH; SCLERODERMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 0347938643     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bernstein RM, Morgan SH, Chapman et al. (1984) Anti-Jo-1 antibody: A marker for myositis with interstitial lung disease. Br Med J, 289: 151-152.
2. Błaszczyk M, Jabłońska J, Szymańska-Jagiełło W, Jarzabek-Chorzelska M et al. (1991): Childhood scleromyositis: An overlap syndrome associated with PM-Scl antibody. Paediatr Dermatol 8: 1-8.
3. Bohan A, Peter JB (1975): Polymyositis and dermatomyositis (part I). N Engl J Med 292: 344-347.
4. Bohan A, Peter JB (1975): Polymyositis and dermatomyositis (part II). N Engl J Med, 292: 403-407.
5. Ge Q, Trieu EP, Targoff IN (1994): Primary structure and functional expression of human glycyl-tRNA synthetases, an autoantigen in myositis. J Biol Chem, 269:28790-28797.
6. Ge Q, Wu Y, James JA, Targoff IN (1996): The analysis of the major reactive region of the 100 kDa protein of PM-Scl autoantigen. Arthritis Rheum 39: 1588-1595.
7. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW et al. (1991): Clinical serologic and immunogenetic findings in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum, 40: 1257-1266.
8. Hirakata M, Mimori T, Akizuki M et al. (1992): Autoantibodies to inflammatory muscle disease. Arthritis Rheum, 35: 449-456.
9. Miller FW (1993): Myositis specific autoantibodies. Touchstones for understanding the inflammatory myopathies. JAMA, 270: 1846-1849.
10. Nishikai M, Reichlin M (1980): Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis; Characterization of Jo-1 antibody system. Arthritis Rheum, 23: 881-888.
11. Plotz PH, Rider LG. Targoff IN et al. (1995): NIH conference. Myositis: Immunologic contributions to understanding cause, pathogenesis and therapy. Ann Intern Med, 122: 715-724.
12. Seeling HP, Moosbrugger I, Ehrfeld H et al. (1995): The major dermatomyositis-specific-Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum, 38: 1389-1399.
13. Sharp GC, Irwin WS, Tan EM et al. (1972): Mixed connective tissue specific antibody to an extractable nuclear antigen (ENA). Am J Med, 52: 148-159.
14. Targoff IN (1988): Laboratory manifestation in polymyositis/dermatomyositis. Clin Dermatol, 6: 76-92.
15. Targoff IN (1992): Autoantibodies in polymyositis. Rheum Dis Clin Morth Am, 18: 455-482.
16. Targoff IN, Miller FW, Medsger TA Jr et al. (1997): Classification criteria for the idiopathic inflammatory myopathies. Curr Opinion Rheumatol, 9: 527-535.
17. Targoff IN, Reichlin M (1988): Immunological aspects. In: Mastaglia FL (ed.) Inflammatory Disease of the Muscle. Blackwell Scientific, Oxford